subscribeSubscribe
AbbVie`s Humira, J&J`s Darzalex top ICER`s annual price-hike list

AbbVie`s Humira, J&J`s Darzalex top ICER`s annual price-hike list
Zoey Becker FIERCE PHARMA
11 Dec 2023
Share Share
Roche`s inavolisib combo cuts breast cancer progression by 57%

Roche`s inavolisib combo cuts breast cancer progression by 57%
PRESS RELEASE
09 Dec 2023
Share Share
Olema Announces Palazestrant Demonstrates Combinability with CDK4/6 Inhibitors

Olema Announces Palazestrant Demonstrates Combinability with CDK4/6 Inhibitors
GLOBENEWSWIRE
05 Dec 2023
Share Share
Olema Oncology to Present at the 2023 Jefferies Healthcare Conference

Olema Oncology to Present at the 2023 Jefferies Healthcare Conference
GLOBENEWSWIRE
30 May 2023
Share Share
Olema Oncology Announces OP-1250 Continues to Demonstrate Attractive Combinability with CDK4/6 Inhibitor Palbociclib in Phase 1b/2 Study

Olema Oncology Announces OP-1250 Continues to Demonstrate Attractive Combinability with CDK4/6 Inhibitor Palbociclib in Phase 1b/2 Study
GLOBENEWSWIRE
11 May 2023
Share Share
Bristol Myers, Pfizer, AbbVie drugs likely to face U.S. price negotiation

Bristol Myers, Pfizer, AbbVie drugs likely to face U.S. price negotiation
REUTERS
14 Mar 2023
Share Share
Pfizer unveils mysterious Ibrance breast cancer nod

Pfizer unveils mysterious Ibrance breast cancer nod
Angus Liu FIERCE PHARMA
01 Feb 2023
Share Share
MSN Group launches world’s first generic drug for advanced breast cancer therapy

MSN Group launches world’s first generic drug for advanced breast cancer therapy
BIOSPECTRUMASIA
19 Jan 2023
Share Share
Dr. Reddy’s acquires trademark rights of breast cancer drug PRIMCYV from Pfizer

Dr. Reddy’s acquires trademark rights of breast cancer drug PRIMCYV from Pfizer
INDIAN PHARMA POST
14 Jan 2023
Share Share
Sun launches Palbociclib, a novel targeted therapy for advanced breast cancer

Sun launches Palbociclib, a novel targeted therapy for advanced breast cancer
INDIANPHARMAPOST
12 Jan 2023
Share Share